Papillary Renal Cell Carcinoma Active Not Recruiting Phase 2 Trials for Axitinib (DB06626)

IndicationStatusPhase
DBCOND0030667 (Papillary Renal Cell Carcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs